September 22, 2016
Medical marijuana is becoming more widely accepted and it is being used for a wide range of conditions. Scientific evidence of its effectiveness for most indications is still slim or nonexistent, but one of the few that are actually well supported is nausea (emesis) from cancer chemotherapy. Marijuana has been used to treat nausea for thousands of years, and there are even FDA-approved THC-based drugs for this purpose. Thus, it is not surprising that pregnant women are using marijuana to control the nausea that often accompanies pregnancy (including the common “morning sickness” and the less common severe nausea called hyperemesis gravidarum). For example, according to a recent analysis, 2.6 percent of women who gave birth in Hawaii between 2009 and 2011 reported using marijuana during their pregnancy, and women who reported severe nausea during pregnancy were significantly more likely to use marijuana.
While it may seem logical to treat the nausea of pregnancy with marijuana, women who do this could be putting their child at risk of neurodevelopmental and other problems. Prenatal exposure to marijuana has long been implicated in possible adverse health outcomes and behavioral abnormalities in childhood and later in life. A recent review and meta-analysis found that women who used marijuana during their pregnancy were more likely to be anemic, and their babies were more likely to have lower birth weight and to require placement in neonatal intensive care than babies of mothers who did not use marijuana. Past studies have also shown links—albeit not consistently—to altered neurodevelopment and to later problems with memory, attention, and problem solving during the school years.
More research to clarify these risks is badly needed. The evidence for brain changes or birth defects is not as extensive or as clear for marijuana as it is for alcohol and tobacco, and it is often impossible in studies to separate out the potential effects of these substances, since many marijuana users also smoke cigarettes and/or drink. Other factors in the environment may also confound the associations. But marijuana’s potential to interfere with cognitive development has theoretical as well as empirical justification. The endocannabinoid system, with which THC interacts, is known to play a significant role in the proper formation of synapses during early brain development. Any substance that interferes with this system could have an impact on how the fetal brain is wiring itself.
Also increasingly popular are synthetic cannabinoids (often called “Spice” or “K2” or “herbal incense”), which are chemically similar to THC and interact with the same cannabinoid receptors, but are often much more potent. Studies of the effects of prenatal exposure to synthetic cannabinoids in animals are showing even clearer signs of neurotoxicity and ability to cause birth defects. A recent study of one potent synthetic cannabinoid showed brain abnormalities, deformations of the eyes, and facial disfigurement (cleft palate) in significant portions of mouse fetuses exposed to a range of dosages of the cannabinoid at day 8 of gestation—roughly equivalent to the third or fourth week of embryonic development in humans (which is before many mothers even know they are pregnant). Even at the lowest dose given, over a quarter of the fetuses had deformed eyes, and the percentage of fetuses with birth defects rose linearly with dose. It is not yet clear how or whether these kinds of effects could translate to humans.
Given what is at stake, it would be inadvisable for pregnant women (or those considering becoming pregnant) to use marijuana or other cannabinoids either recreationally or to treat their nausea. And even though we do not yet have enough data to prove that THC and other cannabinoids interfere with human fetal development, doctors in a position to recommend medical marijuana should be mindful of its potential developmental impacts and not recommend it to treat nausea associated with pregnancy. Future research will be needed to clarify the nature and extent of marijuana’s effects during prenatal development, but at this point, any benefit in reducing nausea is not worth the risks.
Get this Publication
About This Blog
Welcome to my blog, here I highlight important work being done at NIDA and other news related to the science of drug abuse and addiction.
Dr. Nora Volkow: Video Highlights
- National Committee for Quality Assurance (NCQA): Quality Talks, October 2016
Treating Addiction Within the Health Care System
- APA TV, May 2016
APA TV chats with Dr. Nora Volkow, the Director of NIDA to hear about her lecture on drug abuse and the opioid epidemic.
- Kentucky Educational Television, May 2016
One to One with Bill Goodman: Dr. Nora Volkow
- TEDMED, January 2015
Why do our brains get addicted?
- The World Science Festival, May 2013
Meet Pioneer in Science, Dr. Nora Volkow
- Rockburn Presents, November 2012
Dr. Nora Volkow
- Brookhaven National Laboratory WBNL Video, October 2012
Chemistry celebration: FDG: Contribution to Our Understanding of Addiction
- CBS 60 Minutes, April 2012
Hooked: Why Bad Habits Are Hard to Break
- Science Times, June 2011
Dr. Nora Volkow